688177
vs
S
Shanghai Composite
688177
Over the past 12 months, Bio-Thera Solutions Ltd has underperformed Shanghai Composite, delivering a return of +18% compared to the Shanghai Composite's +24% growth.
Stocks Performance
688177 vs Shanghai Composite
Performance Gap
688177 vs Shanghai Composite
Performance By Year
688177 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bio-Thera Solutions Ltd
Glance View
Bio-Thera Solutions Ltd., a beacon of innovation based in Guangzhou, China, swiftly emerged on the biopharmaceutical landscape with its fervent dedication to improving global healthcare. Founded in 2010, this company weaves its narrative through a blend of cutting-edge science and strategic foresight. At its core, Bio-Thera specializes in developing biosimilars – therapeutically equivalent but cost-effective versions of original biologic drugs. By meticulously crafting high-quality biosimilars, Bio-Thera significantly eases the financial burden on healthcare systems, thus broadening access to essential treatments for cancer, autoimmune diseases, and other chronic conditions. This strategic focus not only establishes its reputation in diverse international markets but also positions the company as an instrumental force in the democratization of advanced medicines. Beyond biosimilars, Bio-Thera Solutions strategically extends its reach into novel therapeutic segments. The company embraces a robust pipeline encompassing both innovative biologics and antibody-drug conjugates, which are designed to target cancer cells more precisely, minimizing damage to healthy cells. Bio-Thera generates revenue through a dual strategy: by commercializing its biosimilars in partnerships with global pharmaceutical firms, and by advancing its proprietary new drug candidates either independently or through strategic alliances. This multifaceted approach ensures a steady revenue stream while underpinning their long-term growth aspirations. As Bio-Thera continues to invest in research and development, its narrative of growth is intertwined with a clear mission to push the boundaries of medical science, ultimately improving patient outcomes across the globe.
